Alimera Sciences to Present at the 37th Annual Cowen Health Care Conference
March 03 2017 - 10:05AM
Alimera Sciences (NASDAQ:ALIM), a leader in the commercialization,
research and development of prescription ophthalmic
pharmaceuticals, today announced that Chief Executive Officer, Dan
Myers, will present at the 37th Annual Cowen Health Care
Conference, to be held March 6-8, 2017 at The Boston Marriott
Copley Place, Boston, Massachusetts. Alimera Sciences' presentation
will take place Monday, March 6, 2017, at 4:40 PM Eastern Time.
A live broadcast of the conference presentation will be
available. To access the broadcast, go to the "Investor Relations"
section of the Company's website at www.alimeraciences.com. A
replay of the conference presentation will also be available.
About Alimera SciencesAlimera Sciences, founded
in June 2003, is a pharmaceutical company that specializes in the
commercialization, research and development of prescription
ophthalmic pharmaceuticals. Alimera is presently focused on
diseases affecting the back of the eye, or retina, because these
diseases are not well treated with current therapies and will
affect millions of people in our aging populations. Alimera's
commitment to retina specialists and their patients is manifest in
its product and in its development portfolio designed to treat
early- and late-stage diseases. For more information, please visit
www.alimerasciences.com.
Contact:
CG Capital
877.889.1972
investorrelations@cg.capital
cg.capital
Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From Feb 2024 to Mar 2024
Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From Mar 2023 to Mar 2024